U.S., April 28 -- ClinicalTrials.gov registry received information related to the study (NCT07552454) titled 'Picankibart in Palmoplantar Pustulosis' on April 20.
Brief Summary: 1. Study Design This study is designed as a prospective, single-arm, open-label clinical study. It will be conducted by the Department of Dermatology, the First Affiliated Hospital of Air Force Medical University, and plans to enroll 60 eligible subjects.
2. Study Subjects
Inclusion Criteria
1. Aged 18-65 years, regardless of gender.
2. Patients with a confirmed diagnosis of palmoplantar pustulosis based on clinical manifestations and/or skin histopathology.
3. Failed treatment with at least one conventional systemic agent (regular administration at standard d...